Glucocorticosteroid hormone

Both studies compared UCERIS 9 mg and 6 mg with placebo and included an active reference arm (a mesalamine g in Study 1 and a budesonide* 9 mg not approved for the treatment of UC in Study 2). The primary endpoint was induction of remission after 8 weeks of treatment. Remission was defined as a UCDAI score of ≤1, with subscores of 0 for rectal bleeding, stool frequency, and mucosal appearance and with a ≥1 point reduction in an endoscopy-only score. 2 In both studies, UCERIS 9 mg extended release tablets demonstrated superiority to placebo in inducing remission (Table 4).

Glucocorticosteroid hormone

glucocorticosteroid hormone

Media:

glucocorticosteroid hormoneglucocorticosteroid hormoneglucocorticosteroid hormoneglucocorticosteroid hormoneglucocorticosteroid hormone